CH 271
Alternative Names: Fibronectin-type peptideLatest Information Update: 29 Mar 1995
At a glance
- Originator Takara Shuzo
- Class Antineoplastics; Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 29 Mar 1995 No-Development-Reported for Cancer in Japan (Unknown route)
- 08 Feb 1995 Preclinical development for Cancer in Japan (Unknown route)